vs
碳博士控股（TANH）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
Bio-Techne的季度营收约是碳博士控股的13.8倍（$295.9M vs $21.5M）。Bio-Techne净利率更高（12.8% vs 8.2%，领先4.6%）。碳博士控股同比增速更快（-0.2% vs -6.4%）
碳博士控股是一家总部位于中国的特种制造企业，主要从事竹炭制品、高性能清洁能源材料及环保消费品的研发、生产与销售，客户覆盖中国本土及全球多个市场的消费品、工业材料及新能源领域。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
TANH vs TECH — 直观对比
营收规模更大
TECH
是对方的13.8倍
$21.5M
营收增速更快
TANH
高出6.2%
-6.4%
净利率更高
TECH
高出4.6%
8.2%
损益表 — Q2 2025 vs Q2 2026
| 指标 | | |
|---|---|---|
| 营收 | $21.5M | $295.9M |
| 净利润 | $1.8M | $38.0M |
| 毛利率 | 22.2% | 64.6% |
| 营业利润率 | 10.8% | 18.4% |
| 净利率 | 8.2% | 12.8% |
| 营收同比 | -0.2% | -6.4% |
| 净利润同比 | 59.8% | 68.3% |
| 每股收益（稀释后） | — | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TANHTECH
| Q4 25 | — | $295.9M | ||
| Q2 25 | $21.5M | $317.0M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $297.0M | ||
| Q3 24 | — | $289.5M | ||
| Q2 24 | $21.5M | $306.1M | ||
| Q1 24 | — | $303.4M | ||
| Q4 23 | — | $272.6M |
净利润TANHTECH
| Q4 25 | — | $38.0M | ||
| Q2 25 | $1.8M | $-17.7M | ||
| Q1 25 | — | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | — | $33.6M | ||
| Q2 24 | $1.1M | $40.6M | ||
| Q1 24 | — | $49.1M | ||
| Q4 23 | — | $27.5M |
毛利率TANHTECH
| Q4 25 | — | 64.6% | ||
| Q2 25 | 22.2% | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | 22.3% | 66.4% | ||
| Q1 24 | — | 67.4% | ||
| Q4 23 | — | 64.8% |
营业利润率TANHTECH
| Q4 25 | — | 18.4% | ||
| Q2 25 | 10.8% | -7.5% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 16.0% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | 8.0% | 15.0% | ||
| Q1 24 | — | 22.1% | ||
| Q4 23 | — | 13.9% |
净利率TANHTECH
| Q4 25 | — | 12.8% | ||
| Q2 25 | 8.2% | -5.6% | ||
| Q1 25 | — | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | — | 11.6% | ||
| Q2 24 | 5.1% | 13.3% | ||
| Q1 24 | — | 16.2% | ||
| Q4 23 | — | 10.1% |
每股收益（稀释后）TANHTECH
| Q4 25 | — | $0.24 | ||
| Q2 25 | — | $-0.11 | ||
| Q1 25 | — | $0.14 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $0.21 | ||
| Q2 24 | $0.21 | $0.26 | ||
| Q1 24 | — | $0.31 | ||
| Q4 23 | — | $0.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $35.2M | $172.9M |
| 总债务越低越好 | — | $260.0M |
| 股东权益账面价值 | $128.3M | $2.0B |
| 总资产 | $143.0M | $2.5B |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资TANHTECH
| Q4 25 | — | $172.9M | ||
| Q2 25 | $35.2M | $162.2M | ||
| Q1 25 | — | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | — | $187.5M | ||
| Q2 24 | $34.2M | $152.9M | ||
| Q1 24 | — | $145.3M | ||
| Q4 23 | — | $135.7M |
总债务TANHTECH
| Q4 25 | — | $260.0M | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M | ||
| Q4 23 | — | $447.0M |
股东权益TANHTECH
| Q4 25 | — | $2.0B | ||
| Q2 25 | $128.3M | $1.9B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | $126.0M | $2.1B | ||
| Q1 24 | — | $2.0B | ||
| Q4 23 | — | $2.0B |
总资产TANHTECH
| Q4 25 | — | $2.5B | ||
| Q2 25 | $143.0M | $2.6B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | $142.2M | $2.7B | ||
| Q1 24 | — | $2.7B | ||
| Q4 23 | — | $2.7B |
负债/权益比TANHTECH
| Q4 25 | — | 0.13× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× | ||
| Q4 23 | — | 0.23× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
TANH
| Revenue from China | $20.9M | 97% |
| Revenue directly from foreign countries | $602.2K | 3% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
